Abstract:Developing photothermal agents (PTAs) for tumor therapy has three prerequisites: selectively targeting tumors, efficiently converting near‐infrared (NIR) photoenergy to heat, and degrading after the cure. These make up a combination rarely found in one material. Here a metal‐acid treatment is reported to hydrogenate metal oxide, bestowing the produced HxMoO3 with metal‐like electronic structure which enables harvesting NIR‐II light (1000−1350 nm wavelength). Importantly, created by putting acid protons into oxide, the HxMoO3 nanomaterial can resist attacking from protons in acids but is vulnerable to hydroxyl ions in alkaline. After entering biological organism, HxMoO3 PTAs persist long in acidic tumor microenvironment (TME, extracellular pH 6.5–6.9) while degrade quickly under the normal physiological environment (pH 7.2−7.4), naturally causing tumor‐selective accumulation. Under 1064 nm NIR‐II illumination, the HxMoO3 achieves a high photothermal conversion efficiency of 60.9%, leading to a high tumor inhibition rate of ≈97.25%. Such a novel PTAs integrates merits of metal and oxide, opening a door of smart photothermal therapy with self‐adaptive tumor‐accumulation and automatic degradation after tumor hyperthermia. Hydrogenated metal oxides are prepared by metal‐acid treatment, resulting in pH‐selective materials that are stable in acids but vulnerable in alkaline solutions. It led to a novel type of smart photothermal agents that target only onto tumors with acidic condition and degrade in healthy cells. They not only retain the good biocompatibility and low cytotoxicity of their parent oxide material, but also combine merits of metals with highly efficient photothermal conversion and thermal conductivity, serving as excellent photothermal reagents working in the near infrared‐Ⅱ biowindow.

Design and mechanism of core-shell TiO 2 nanoparticles as a high-performance photothermal agent.

Design and mechanism of core–shell TiO<sub>2</sub> nanoparticles as a high-performance photothermal agent

Photothermal Therapy by Using Titanium Oxide Nanoparticles

Octahedral Shaped PbTiO 3 -TiO 2 Nanocomposites for High-Efficiency Photocatalytic Hydrogen Production.

Facile Preparation of Biocompatible Ti2O3 Nanoparticles for Second Near-Infrared Window Photothermal Therapy.

Hydrogenated Oxide Material for Self‐Targeting and Automatic‐Degrading Photothermal Tumor Therapy in the NIR‐II Bio‐Window

High-Performance Photothermal Conversion of Narrow-Bandgap Ti 2 O 3 Nanoparticles.

Biocompatible Two-dimensional Titanium Nanosheets for Efficient Plasmonic Photothermal Cancer Therapy

Boosting Interfacial Interaction in Hierarchical Core–Shell Nanostructure for Highly Effective Visible Photocatalytic Performance

Optimizing Ag-Pt core-shell nanostructures for solar energy conversion, plasmonic photocatalysis, and photothermal catalysis

Titanium Dioxide Nano-Heterostructure with Nanoparticles Decorating Nanowires for High-Performance Photocatalysis

Plasmon-assisted Nanophase Engineering of Titanium Dioxide for Improved Performances in Single-Particle Based Sensing and Photocatalysis.

Photothermal Hydrogen Production Using Noble-Metal-Free Ti@TiO2 Core–Shell Nanoparticles under Visible–NIR Light Irradiation

Oxygen vacancy-engineered BaTiO3 nanoparticles for synergistic cancer photothermal, photodynamic, and catalytic therapy

Side-chain Engineering of Organic Photothermal Agents for Boosting Further Red-Shifted Absorption and Higher Photothermal Therapeutic Effect

Perylene Diimide Oligomer Nanoparticles with Ultrahigh Photothermal Conversion Efficiency for Cancer Theranostics

Low-Temperature Photothermal Therapy Platform Based on Pd Nanozyme-Modified Hydrogenated TiO 2

Hydrothermal Synthesis of Core–shell TiO2 to Enhance the Photocatalytic Hydrogen Evolution

Synthesis and Evaluation of Titanium Oxide Modified Mussel Inspired Nanoparticles for Synergetic Photothermal and Photodynamic Effect

Pt Nanohelices with Highly Ordered Horizontal Pore Channels As Enhanced Photothermal Materials

1T-Phase Dirac Semimetal PdTe2 Nanoparticles for Efficient Photothermal Therapy in the NIR-II Biowindow.